Skip to main content
    E

    Enovis Corp (ENOV)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $19.35
    +0.78 (+4.20%)

    Market Cap: $1.05B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(37/39)
    Avg Surprise
    +8.95%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.77
    Range$0.71 - $0.83
    13 analysts
    EPS Revisions
    1
    0
    7d
    0
    12
    30d
    EPS Estimate DriftChange to current
    90d ago$0.84-8.7%
    60d ago$0.84-8.7%
    30d ago$0.77-0.9%
    7d ago$0.77-0.9%
    Current$0.77
    Revenue Consensus
    $557M
    Range$552M - $563M
    13 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.20
    Range$1.14 - $1.29
    13 analysts
    Revenue Consensus
    $628M
    Range$617M - $639M
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.20---
    Sep 26EST
    		-$0.77---
    Jun 26
    Reported Aug 6
    		$0.76$0.79-3.80%Miss-3.8%
    Mar 26
    Reported May 7
    		$0.89$0.81+9.88%Beat+9.9%
    Dec 25
    Reported Feb 26
    		$0.95$0.81+17.28%Beat-3.1%
    Sep 25
    Reported Nov 6
    		$0.75$0.65+15.38%Beat+2.7%
    Jun 25
    Reported Aug 7
    		$0.79$0.74+6.76%Beat+27.4%
    Mar 25
    Reported May 8
    		$0.81$0.74+9.46%Beat+62.0%
    Dec 24
    Reported Feb 26
    		$0.98$0.92+7.02%Beat+24.1%
    Sep 24
    Reported Nov 6
    		$0.73$0.61+19.67%Beat+30.4%
    Jun 24
    Reported Aug 7
    		$0.62$0.59+5.08%Beat+1.6%
    Mar 24
    Reported May 2
    		$0.50$0.48+4.17%Beat+13.6%
    Dec 23
    Reported Feb 22
    		$0.79$0.74+6.76%Beat+9.7%
    Sep 23
    Reported Nov 7
    		$0.56$0.54+3.70%Beat-5.1%
    Jun 23
    Reported Aug 3
    		$0.61$0.52+17.31%Beat+3.4%
    Mar 23
    Reported May 4
    		$0.44$0.38+15.79%Beat+18.9%
    Dec 22
    Reported Feb 23
    		$0.72$0.66+9.09%Beat-59.3%
    Sep 22
    Reported Nov 2
    		$0.59$0.48+22.92%Beat-63.6%
    Jun 22
    Reported Aug 4
    		$0.59$0.50+18.00%Beat-64.9%
    Mar 22
    Reported May 10
    		$0.37$0.35+5.71%Beat-72.0%
    Dec 21
    Reported Feb 22
    		$1.77$1.74+1.72%Beat+15.7%
    Sep 21
    Reported Nov 4
    		$1.62$1.61+0.62%Beat+31.7%
    Jun 21
    Reported Jul 28
    		$1.68$1.61+4.35%Beat+522.2%
    Mar 21
    Reported Apr 29
    		$1.32$1.19+10.92%Beat+15.8%
    Dec 20
    Reported Feb 18
    		$1.53$1.49+2.68%Beat-16.4%
    Sep 20
    Reported Oct 29
    		$1.23$1.17+5.13%Beat-18.0%
    Jun 20
    Reported Aug 6
    		$0.27$0.18+50.00%Beat-83.3%
    Mar 20
    Reported May 7
    		$1.14$1.12+1.79%Beat-28.3%
    Dec 19
    Reported Feb 21
    		$1.83$1.67+9.58%Beat-11.6%
    Sep 19
    Reported Oct 31
    		$1.50$1.42+5.63%Beat-7.4%
    Jun 19
    Reported Aug 6
    		$1.62$1.84-11.96%Miss-11.5%
    Mar 19
    Reported May 8
    		$1.59$1.48+7.43%Beat+10.4%
    Dec 18
    Reported Feb 13
    		$2.07$1.90+8.95%Beat+53.3%
    Sep 18
    Reported Oct 25
    		$1.62$1.58+2.53%Beat+28.6%
    Jun 18
    Reported Aug 6
    		$1.83$1.56+17.31%Beat+41.9%
    Mar 18
    Reported May 3
    		$1.44$1.28+12.50%Beat+37.1%
    Dec 17
    Reported Feb 6
    		$1.35$1.29+4.65%Beat-2.2%
    Sep 17
    Reported Nov 6
    		$1.26$1.23+2.44%Beat-
    Jun 17
    Reported Jul 28
    		$1.29$1.29+0.00%Beat-
    Mar 17
    Reported May 5
    		$1.05$0.89+17.98%Beat-
    Dec 16
    Reported Feb 2
    		$1.38$1.32+4.55%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%

    Key Metrics

    Valuation
    P/E Ratio5.78EV/EBITDAN/A
    Price/FCF17.53xFCF Yield5.70%
    Profitability
    Profit Margin-48.00%Operating Margin4.19%
    ROE-54.10%ROIC-36.68%
    Financial Health
    Debt/Equity0.91xInterest Coverage-30.84x
    Current Ratio1.98xQuick Ratio1.00x
    Trading Statistics
    Beta1.48Avg Volume1.59M
    52-Week High$34.2852-Week Low$16.70

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$18.25
    SMA 20$18.25
    SMA 50$21.01
    SMA 200$23.41
    EMA 10$18.47
    EMA 20$18.67
    EMA 50$20.42
    EMA 200$23.78

    MACD

    Line: -0.56Signal: -0.91Hist: 0.35

    ADX

    ADX: 17.1+DI: 24.7-DI: 19.3

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down80.0
    PSAR$16.80

    Bollinger Bands

    Upper Band$19.16
    Lower Band$17.34
    %B Position997%(Upper)
    Band Width1.11

    RSI (14-Day)

    Neutral
    52.0

    Momentum Oscillators

    Stoch %K89.5
    Stoch %D79.1
    Williams %R-3.3
    ROC (10d)7.2%
    Momentum1.30
    CCI (20d)189.5
    MFI (14d)54.2

    Volatility Measures

    ATR (14d)$0.96(5.0%)
    StdDev (20d)0.45
    Hist Vol38.2%(Moderate)

    Volume Flow

    VWAP$19.07
    OBV-31.3M
    AD Line-12.5M
    CMF (20d)0.230

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio0.8x
    VWMA (20d)$18.21

    Pivot Points

    R3$19.48
    R2$19.17
    R1$18.87
    Pivot Point$18.55
    S1$18.25
    S2$17.94
    S3$17.64

    Advanced Oscillators

    TSI-15.57
    Ultimate Osc65.4
    KST-110.30

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$582.78M$589.15M$575.76M$548.91M$564.54M$558.83M$560.98M$505.22M$525.16M$516.27M$455.02M$417.52M
    Cost of Revenue$223.53M$223.67M$226.34M$220.00M$229.85M$226.60M$253.46M$218.76M$236.28M$218.37M$190.63M$174.56M
    Gross Profit$359.25M$365.49M$349.42M$328.91M$334.70M$332.23M$307.52M$286.46M$288.88M$297.90M$264.39M$242.97M
    Operating Expenses$341.84M$358.95M$851.60M$887.40M$351.49M$379.00M$972.27M$318.20M$333.10M$332.91M$270.14M$263.46M
    R&D$31.69M$31.53M$31.36M$29.74M$30.70M$28.53M$23.95M$20.49M$23.48M$23.38M$18.32M$19.90M
    SG&A$263.73M$282.81M$270.44M$263.62M$267.07M$269.02M$257.71M$249.85M$264.10M$255.69M$211.01M$204.25M
    Operating Income$17.41M$6.53M$-502,175,000$-558,488,000$-16,796,000$-46,769,000$-664,749,000$-31,737,000$-44,219,000$-35,014,000$-5,755,000$-20,492,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$8.04M$9.17M$7.51M$8.83M$9.29M$9.19M$9.07M$11.07M$16.97M$20.00M$11.59M$5.77M
    Income Before Tax$7.46M$634,000$-509,547,000$-566,868,000$-25,654,000$-57,349,000$-673,726,000$-42,601,000$-27,352,000$-79,245,000$7.66M$-25,503,000
    Income Tax Expense$8.50M$9.04M$9.26M$4.00M$10.80M$-1,769,000$29.90M$-9,096,000$-8,908,000$-7,404,000$4.59M$-6,052,000
    Net Income$-1,036,000$-8,450,000$-520,454,000$-570,913,000$-36,548,000$-55,705,000$-703,200,000$-31,262,000$-18,512,000$-71,841,000$3.08M$-2,840,000
    EBITDA$86.53M$83.16M$-425,022,000$-483,660,000$55.19M$23.27M$-590,255,000$39.69M$55.38M$14.15M$75.86M$35.73M
    EBIT$15.50M$9.80M$-502,034,000$-558,040,000$-16,360,000$-48,161,000$-664,657,000$-31,535,000$-10,383,000$-59,249,000$19.24M$-19,735,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ENOV

    News

    Enovis Is Maintained at Buy by Needham

    Needham has reiterated its Buy rating on Enovis, a medical technology company. The analyst's decision indicates continued confidence in the company's prospects. This report provides an overview of recent analyst ratings...

    Moomoo•10/12/26•Bullish

    Needham Cuts Price Target on Enovis to $34 From $52, Keeps Buy Rating

    Needham has revised its price target for Enovis (ENOV) shares down to $34 from $52, while maintaining a Buy rating on the stock. This adjustment comes after other firms like BofA Securities and BMO Capital also recently...

    marketscreener.com•10/12/26•Neutral

    Needham cuts Enovis stock price target on robotics deal impact

    Needham has lowered its price target for Enovis Corp (NYSE: ENOV) from $52 to $34, while maintaining a Buy rating...

    Investing.com•10/12/26•Somewhat-Bearish

    Needham cuts Enovis stock price target on robotics deal impact By Investing.com

    Needham has lowered its price target for Enovis Corp (NYSE: ENOV) from $52 to $34, while maintaining a Buy rating. This adjustment follows Enovis's anticipated acquisition of eCential Robotics...

    Investing.com India•10/12/26•Bearish

    Enovis (ENOV), Why Is Fresh Attention Building Now?

    Enovis (ENOV) is garnering fresh attention as its upcoming investor call on November 5, 2026, approaches, set to review third-quarter results. Despite recent share price weakness, with a 40.4% drop over the last year...

    Yahoo! Finance Canada•10/10/26•Somewhat-Bullish

    ENOV Valuation and Fair Value

    P/E
    5.8x
    Forward P/E
    4.6x
    P/FCF
    17.5x
    PEG
    1.9x
    P/B
    0.8x
    See GNG's fair value

    ENOV Profitability: Margins, ROIC and FCF

    Gross margin
    61.1%
    Operating margin
    4.2%
    Net margin
    -48.0%
    ROIC
    -36.7%
    ROE
    -54.1%
    FCF margin
    2.8%
    FCF yield
    5.7%

    ENOV Competitors

    CompanyTicker
    Immatics NVIMTX
    Janux Therapeutics IncJANX
    Replimune Group IncREPL
    CureVac NVCVAC
    Procept Biorobotics CorpPRCT
    Artivion IncAORT
    Teladoc IncTDOC
    HealthStream IncHSTM

    Sector: Healthcare

    ENOV Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    10
    Hold
    1
    Sell
    0
    Strong Sell
    0

    ENOV Bull Case vs Bear Case

    Bull case

    • ENOV beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 92.3% of ENOV's analyst ratings are Buy or Strong Buy.

    Bear case

    • ENOV has a -48.0% net profit margin.

    ENOV Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    10.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.77
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 12 down

    ENOV Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About ENOV

    Does ENOV pay dividends?

    Enovis Corp (ENOV) has a dividend payment track record. See the ENOV dividend history page for its current payment status, TTM yield, and recorded payments.

    What is ENOV's P/E ratio?

    Enovis Corp has a price-to-earnings (P/E) ratio of 5.78.

    What is ENOV's market cap?

    Enovis Corp (ENOV) has a market capitalization of $1.05B with a current stock price of $19.35.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In